New painkiller JKN2306 passes first safety check in healthy volunteers
NCT ID NCT07412938
First seen Feb 18, 2026 · Last updated May 10, 2026 · Updated 10 times
Summary
This early-stage study tested a single dose of a new drug called JKN2306 in 44 healthy adults in China. The main goal was to check if it is safe and how the body processes it, including whether a high-fat meal changes its effects. The study did not treat pain directly but gathered important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 214000, China
Conditions
Explore the condition pages connected to this study.